Friday File: 3 “G’s” Could Make Your 2024 Spectacular

The two years have been some of the trickiest in financial history.

The Fed’s aggressive rate hikes have proved harsh to a financial world without the experience to deal with them. 

And in wars, resource market mayhem, and everything else and you’ve got the perfect recipe for  general economic malaise. 

But things are looking up. Way up.

We’re not going to predict exactly what will happen, but it’s a safe bet the Fed will be much more accommodative and there’s some real bull market and potential bubbles building.

We’re calling them the three “G’s” and they’re packed with major potential in 2024. 

Here they are:

Gold

New all-time highs, yet still quiet.

Historically, there are multiple stages in a bull market in any sector.

Gold is still in the early ones.

It’s been a long time, but gold could be in for a sustained run. 

Just look at uranium to see a potential roadmap of where things can go from here.

Gas (and oil)

Oil and energy are out of favor at the moment, but don’t expect that to last. 

The oil industry continues to be the most underinvested in the world.

Oil prices can and will dip, but everything is in place for a long-term, sustained bull market.

On top of that, trillions of dollars have been invested in dubiously economic energy projects. 

These major investments are not viable without much higher energy prices.

Expect further supply constraints to persist because the most powerful and influential people made a bet on higher energy prices and they are going to make it happen.

GLP-1 (e.g. Ozempic)

This might be one the least understood by the investing public. 

GLP-1 is the active part of drugs like Ozempic and these drugs got a lot of attention in 2023.

These diabetes treatments are being used by at least hundreds of thousands (probably millions) or people as a weight loss treatment.

Some of the rosier forecasts for GLP-1 market potential at $100 billion/yr by 2030 after all the U.S. health insurers start covering the drug and more studies are completed to improve effectiveness and safety.

But these are extremely powerful drugs, but they also have many more potential applications beyond diabetes and weight loss.

We’re not saying GLP-1 drugs are an ideal solution to any problem. 

But we can see how this drug is already on course to be widely-used and enormously profitable.

These are the big three we can see coming up in 2024. 

If one or two of them hit, it will be great year. 

If all three do, watch out. 

We’ll be back with more in the days and weeks ahead.

I’m glad you’re going to be a part of it.

All the best,

Andrew Mickey